SCHERING-PLOUGH 10% U.S. SALES GROWTH LED BY CLARITIN's $130 MIL. IN 1993; MMD's SELDANE SALES DOWN 15% TO $747 MIL.; COGNEX SELLS $27 MIL.
Executive Summary
Schering-Plough's nonsedating antihistamine Claritin posted sales of $130 mil. in less than nine months on the U.S. market in 1993, the company reported Jan. 27.